2 stories tagged by Digg
Science
STAT reports the agreement is for a pill from China’s Hengrui Pharma that remains experimental.
World & Business
The Wall Street Journal reports that Hengrui Pharma is developing the treatment and that the deal could be worth up to $2.6 billion.
